Additionally, the combined targeted therapy, including targeted agents (which were against EGFR, ALK, BRAF, IGF-1R, MET(c-MET), VEGF) and antibody–drug conjugate (ADC), as well as cancer vaccines, was among the top three most effective treatment interventions in this study. The gene discussed is IGF1R; the disease is cancer.